241 related articles for article (PubMed ID: 34774266)
1. Controversies in Breast Cancer Surgery.
Gutnik L; Fayanju OM
Surg Clin North Am; 2021 Dec; 101(6):1033-1044. PubMed ID: 34774266
[TBL] [Abstract][Full Text] [Related]
2. Rate and predictors of nodal pathological complete response following neoadjuvant endocrine treatment in clinically biopsy-proven node-positive breast cancer patients.
Schipper RJ; de Bruijn A; Voogd AC; Bloemen JG; Van Riet YE; Vriens BEP; Smidt ML; Siesling S; van der Sangen MJC; Nieuwenhuijzen GAP
Eur J Surg Oncol; 2021 Aug; 47(8):1928-1933. PubMed ID: 34030918
[TBL] [Abstract][Full Text] [Related]
3. Update on the management of early-stage breast cancer.
Heilat GB; Brennan ME; French J
Aust J Gen Pract; 2019 Sep; 48(9):604-608. PubMed ID: 31476829
[TBL] [Abstract][Full Text] [Related]
4. De-escalation of Axillary Surgery in the Neoadjuvant Chemotherapy (NACT) Setting for Breast Cancer: Is it Oncologically Safe?
Wazir U; Mokbel K
Anticancer Res; 2020 Oct; 40(10):5351-5354. PubMed ID: 32988853
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic escalation - De-escalation: Data from 15.508 early breast cancer treated with upfront surgery and sentinel lymph node biopsy (SLNB).
Houvenaeghel G; Lambaudie E; Cohen M; Classe JM; Reyal F; Garbay JR; Giard S; Chopin N; Martinez A; Rouzier R; Daraï E; Colombo PE; Coutant C; Gimbergues P; Azuar P; Villet R; Tunon de Lara C; Barranger E; Sabiani L; Goncalves A
Breast; 2017 Aug; 34():24-33. PubMed ID: 28475932
[TBL] [Abstract][Full Text] [Related]
6. Validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: Preliminary results.
Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Chaves-Benito MA; Ayala-De La Peña F; Nieto-Olivares A; Aguayo-Albasini JL
Surg Oncol; 2019 Sep; 30():52-57. PubMed ID: 31500785
[TBL] [Abstract][Full Text] [Related]
7. [New surgery].
Chauvet MP
Presse Med; 2019 Oct; 48(10):1123-1130. PubMed ID: 31653543
[TBL] [Abstract][Full Text] [Related]
8. [Contralateral axillary drainage in breast tumor recurrence].
Sabaté M; Roca I; Córdoba O; Kysiel N; Rubio I; Castell J
Rev Esp Med Nucl; 2011; 30(5):327-8. PubMed ID: 21514976
[No Abstract] [Full Text] [Related]
9. De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study.
Simons JM; Koppert LB; Luiten EJT; van der Pol CC; Samiei S; de Wilt JHW; Siesling S; Smidt ML
Breast Cancer Res Treat; 2020 Apr; 180(3):725-733. PubMed ID: 32180074
[TBL] [Abstract][Full Text] [Related]
10. Neo-Adjuvant chemotherapy and its affects to the axilla-Can we safely downgrade axillary surgery to mirror the approach in the breast.
Batt J; Chambers A; Al-Allak A; Vestey S; Hunt R; Massey E; Fowler C
Breast J; 2020 Sep; 26(9):1667-1672. PubMed ID: 32767467
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy in patients with breast cancer: Does response in the breast predict axillary node response?
Morgan C; Stringfellow TD; Rolph R; Kovacs T; Kothari A; Pinder SE; Hamed H; Sever AR
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):522-526. PubMed ID: 31740186
[TBL] [Abstract][Full Text] [Related]
12. Lower nodal counts in axillary dissection following neoadjuvant chemotherapy: are there implications?
Callcut RA; Breslin TM
Am J Surg; 2006 Jun; 191(6):830-1. PubMed ID: 16720160
[No Abstract] [Full Text] [Related]
13. [Breast-conserving therapy in breast cancer].
Marcollet A; Doridot V; Nos C
Rev Prat; 2004 Apr; 54(8):847-53. PubMed ID: 15274458
[TBL] [Abstract][Full Text] [Related]
14. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast.
Schwartz GF; Tannebaum JE; Jernigan AM; Palazzo JP
Cancer; 2010 Mar; 116(5):1243-51. PubMed ID: 20087958
[TBL] [Abstract][Full Text] [Related]
15. Conservative surgery after neoadjuvant chemotherapy in patients with operable breast cancer.
Franceschini G; Di Leone A; Natale M; Sanchez MA; Masett R
Ann Ital Chir; 2018; 89():290. PubMed ID: 30352955
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy and neoadjuvant chemotherapy in the management of early breast cancer: Safety considerations and timing.
Edge J; Nietz S
S Afr Med J; 2017 May; 107(6):497-500. PubMed ID: 28604321
[TBL] [Abstract][Full Text] [Related]
17. Axillary surgery in breast cancer: the beginning of the end.
Dumitru D; Khan A; Catanuto G; Rocco N; Nava MB; Benson JR
Minerva Chir; 2018 Jun; 73(3):314-321. PubMed ID: 29589679
[TBL] [Abstract][Full Text] [Related]
18. Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer.
Kuerer HM; Newman LA; Buzdar AU; Hunt KK; Dhingra K; Buchholz TA; Binkley SM; Ames FC; Feig BW; Ross MI; Hortobagyi GN; Singletary SE
Am J Surg; 1998 Dec; 176(6):502-9. PubMed ID: 9926779
[TBL] [Abstract][Full Text] [Related]
19. Wire guided localisation for targeted axillary node dissection is accurate in axillary staging in node positive breast cancer following neoadjuvant chemotherapy.
Balasubramanian R; Morgan C; Shaari E; Kovacs T; Pinder SE; Hamed H; Sever AR; Kothari A
Eur J Surg Oncol; 2020 Jun; 46(6):1028-1033. PubMed ID: 31879050
[TBL] [Abstract][Full Text] [Related]
20. The need for targeted research into breast cancer in the elderly.
Wyld L; Reed MW
Br J Surg; 2003 Apr; 90(4):388-99. PubMed ID: 12673739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
